Press Release

Vasopressin for Vasoplegic Shock Market Size, Share, Growth, Regional Trend, Leading Players Updates, Impact of Covid-19 on Industry and Future Plans by Forecast to 2027

The global ’vasopressin for vasoplegic shock market‘ size is expected to gain momentum by reaching USD 2,657.9 million by 2027, while exhibiting a stellar CAGR of 14.8% between 2020 and 2027. This is attributable to the increasing prevalence of cardiovascular surgeries that propels the demand for vasopressin for vasoplegic shock across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Vasopressin for Vasoplegic Shock Market Size, Share & COVID-19 Impact Analysis, By Application (Sepsis, Post Cardiac Surgery, and Others) Regional Forecast, 2020-2027.” The report further mentions that the market stood at USD 890.9 million in 2019.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/vasopressin-for-vasoplegic-shock-market-104065

Rising Cardiac Syndrome Cases amid COVID-19 to Boost Growth

The recent spike in the cases of people suffering from the novel coronavirus disease is expected to surge the cardiac syndrome risk amongst people susceptible to contracting it. This is leading the pharmaceutical sector to focus on developing advanced vasopressin drugs for treatment purposes. This is expected to bode well for the growth of the global market in the near future.

Vasoplegia is a type of syndrome that involves pathologically low systemic vascular resistance. It further leads to reduced blood pressure amid presence of a raised cardiac output. The growing adoption of vasopressin for vasoplegic shock treatment is gaining popularity owing to its efficiency in treating the syndrome.

What does the Report Include?

The market report includes a detailed assessment of various drivers and restraints, opportunities, and challenges that the market will face during the projected horizon. Additionally, the report provides comprehensive insights into the regional developments of the market, affecting its growth during the forecast period. It includes information sourced from the advice of expert professionals from the industry by our research analysts using several research methodologies. The competitive landscape offers further detailed insights into strategies such as product launches, partnership, merger and acquisition, and collaborations adopted by the companies to maintain market stronghold between 2020 and 2027.

Table Of Content :

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
  • Recent Industry Developments Such as Mergers & Acquisitions
  • Regulatory Scenario for Key Countries
  • New Product Launch
  • Statistics on Prevalence of Cardiac Disorders for Key Countries/Regions
  • Pipeline Analysis

Continue…

DRIVING FACTORS

Increasing Incidence of Cardiovascular Surgeries to Augment Growth

According to the Centers for Disease Control and Prevention (CDC), every year about 340,000 Coronary Artery Bypass Grafting (CABG) procedures are performed in the U.S. The increasing number of cardiovascular surgeries propels the demand for vasopressin to control the blood flow. Additionally, the growing number of CABG procedures and sepsis patients are boosting the demand for innovative vasopressin treatment options. This is expected to bode well for the global vasopressin for vasoplegic shock market growth during the forecast period.

For more information visit : 

https://www.fortunebusinessinsights.com/vasopressin-for-vasoplegic-shock-market-104065

SEGMENTATION

Post Cardiac Surgery Segment Held 25.2% in 2019

The post cardiac segment, based on application, held a market share of about 25.2% in 2019 and is likely to gain momentum owing to the increasing number of cardiac surgeries that require efficient post-cardiac treatment globally.

REGIONAL INSIGHTS

Increasing Prevalence of Sepsis in North America to Favor Growth

Among all the regions, North America stood at USD 561.3 million in 2019 and is expected to hold the highest position in the global market in the forthcoming years. This is ascribable to the increasing prevalence of sepsis that drives the demand for advanced vasopressin for vasoplegic shock treatment procedures in the region.

The market in Europe is expected to experience a significant growth backed by surging investments in R&D by the government as well as major companies to develop advanced vasopressin for vasoplegic shock treatment between 2020 and 2027.

COMPETITIVE LANDSCAPE

Prominent Companies Focus on Investment in R&D Activities to Develop Innovative Vasopressin for Vasoplegic Shock

The global vasopressin for vasoplegic shock market is fragmented by the presence of key players that are focusing on raising investments to develop advanced vasopressin for vasoplegic shock treatment. Additionally, the major companies are striving to maintain their presence in the global marketplace by adopting strategies such as partnership, collaboration, and merger and acquisition to gain a competitive edge over their rivals during the forecast period.

Industry Development:

  • April 2018 – Eagle Pharmaceuticals, Inc announced the approval of its new drug application, ANDA for 1ml vasopressin injection. The product is a original generic version of Endo International plc’s Vasostrict formulation.

List of the Companies Profiled in the Market:

  • Endo International plc (Dublin, Ireland)
  • AMOMED Pharma (Vienna, Austria)
  • La Jolla Pharmaceutical Company (California, U.S.)
  • Pfizer Inc. (New York, U.S.)
  • Ferring Pharmaceuticals (Saint-Prex, Switzerland)
  • Fresenius Kabi Canada (Toronto, Canada)
  • Astellas Pharma (Tokyo, Japan)
  • Eagle Pharmaceuticals, Inc. (New Jersey, U.S.)
  • Others

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vasopressin-for-vasoplegic-shock-market-104065

Global Vasopressin for Vasoplegic Shock Market Segmentation :

By Application

  • Sepsis
  • Post Cardiac Surgery
  • Others

By Geography

  • North America
    • By Application
    • By Country
  • Europe
    • By Application
    • By Country/Sub-region
  • Asia Pacific
    • By Application
    • By Country/Sub-region
  • Latin America
    • By Application
    • By Country/Sub-region
  • The Middle East & Africa
    • By Application
    • By Country/Sub-region

 

More Trending Topics from Fortune Business Insights :

Perfusion Systems Market Size, Share, Growth, Regional Trend, Leading Players Updates, Impact of Covid-19 on Industry and Future Plans by Forecast to 2027

Recombinant Proteins Market Size, Share, Growth, Regional Trend, Leading Players Updates, Impact of Covid-19 on Industry and Future Plans by Forecast to 2027

Plastic Injection Molding For Medical Device Market Size, Share, Growth, Regional Trend, Leading Players Updates, Impact of Covid-19 on Industry and Future Plans by Forecast to 2027

Depression Treatment Therapy Market Size, Share, Growth, Regional Trend, Leading Players Updates, Impact of Covid-19 on Industry and Future Plans by Forecast to 2027

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: [email protected]

 

Related Reports :

ECG Devices Market

ECG Devices Market Size

ECG Devices Market Share

ECG Devices Market Trends

ECG Devices Market Growth

ECG Devices Market Analysis

ECG Devices Market Business Opportunities

ECG Devices Market Key Players

ECG Devices Market Demand

ECG Devices Market Competitive Landscape

ECG Devices Market Segments

ECG Devices Market Overview

ECG Devices Market Industry

ECG Devices Market Stastistic

ECG Devices Market Devlopment Strategy

ECG Devices Market Future Growth

ECG Devices Market Research Methodology

ECG Devices Market Drivers

ECG Devices Market Manufacturers

ECG Devices Market Revenue

ECG Devices Market Growth Analysis

ECG Devices Market Search Analysis

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close